|Bid||402.91 x 1000|
|Ask||424.96 x 900|
|Day's range||400.93 - 414.46|
|52-week range||219.79 - 460.21|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||53.46|
|Earnings date||03 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||450.09|
WILMINGTON, Mass., October 18, 2021--Charles River Laboratories International, Inc. (NYSE: CRL) and ATEM Structural Discovery (ATEM) today announced the formation of a strategic partnership to provide clients access to ATEM’s cryo-electron microscopy (cryo-EM) service solutions. Cryo-EM is a technique that determines the 3D structures of proteins and is utilized to identify how proteins function, how they malfunction in disease and the most effective way to target them with therapies.
Today we're going to take a look at the well-established Charles River Laboratories International, Inc. ( NYSE:CRL...
WILMINGTON, Mass., October 13, 2021--Charles River Laboratories schedules Third-Quarter 2021 earnings release and conference call